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Objective: Dosimetric evaluation of air column in gastro-
intestinal (GI) structures in intensity modulated radiation 
therapy (IMRT) of pancreatic cancer.
Methods: Nine sequential patients were retrospectively 
chosen for dosimetric analysis of air column in the GI 
apparatus in pancreatic cancer using cone beam CT 
(CBCT). The four-dimensional CT (4DCT) was used for 
target and organs at risk (OARs) and non-coplanar IMRT 
was used for treatment. Once  a  week, these patients 
underwent CBCT for air filling, isocentre verification and 
dose calculations retrospectively.
Results: Abdominal air column variation was as great 
as  ±80% between weekly CBCT and 4DCT. Even with 
such a large air column in the treatment path for pancre-
atic cancer, changes in anteroposterior dimension were 
minimal (2.8%). Using IMRT, variations in air column did 
not correlate dosimetrically with large changes in target 
volume. An average dosimetric deviation of mere −3.3% 
and a maximum of −5.5% was observed.
Conclusion: CBCT revealed large air column in GI 
structures; however, its impact is minimal for target 
coverage. Because of the inherent advantage of 
segmentation in IMRT, where only a small fraction of a 
given beam passes through the air column, this tech-
nique might have an advantage over 3DCRT in treating 
upper GI malignancies where the daily air column can 
have significant impact.
Advances in knowledge: Radiation treatment of pancre-
atic cancer has significant challenges due to positioning, 
imaging of soft tissues and variability of air column in 
bowels. The dosimetric impact of variable air column is 
retrospectively studied using CBCT. Even though, the 
volume of air column changes by ± 80%, its dosimetric 
impact in IMRT is minimum.
Cite this article as:
Estabrook NC, Corn JB, Ewing MM, Cardenes HR, Das IJ. Dosimetric impact of gastrointestinal air column in radiation treatment of 
pancreatic cancer. Br J Radiol 2018; 91: 20170512.
https:// doi. org/ 10. 1259/ bjr. 20170512
Full PAPeR
Dosimetric impact of gastrointestinal air column in 
radiation treatment of pancreatic cancer
1Neil C estAbROOk, MD, 1JONAthAN b CORN, bs, CMD, Rt, 2MARveNe M ewiNg, bs, CMD, 
3higiNiA R CARDeNes, MD, PhD and 4iNDRA J DAs, PhD, FAstRO
1Indiana University Health Arnett Cancer Care, Lafayette, IN, USA
2Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, USA
3The Arnold Center for Radiation Oncology, New York Presbyterian Queens Weill Cornell Medicine, New York, NY, USA
4Department of Radiation Oncology, New York University Langone Medical Center, New York, NY, USA
Address correspondence to: Prof Indra J Das 
E-mail:  indra. das@ nyumc. org
iNtRODuCtiON
Radiation treatment of upper gastrointestinal (GI) tract 
malignancies requires consideration of many parameters 
for accurate delivery of prescribed dose to the appropri-
ately defined target. In particular, these include respiratory 
motion, gastric motility, air volume, as well as other vari-
abilities inherent in the set-up and delivery of external beam 
radiation treatment. Four-dimensional CT (4DCT) scan has 
been proposed for treatment planning purposes to account 
for the motion associated with breathing in treating upper 
GI tumours.1–5 Structural changes due to inter-fractional 
gastric motion during radiation therapy can be delineated 
with use of surgical clips in the gastric mucosa detected on 
CT scan3 and intra- and inter-fractional target deforma-
tion due to gastric motion have been described using CT 
images with corresponding estimations for necessary target 
volume changes.4,5 However, even surgical clips may not be 
suitable with large variability due to gastric motion, where 
landmarks and clinical judgement prevails. Adaptive treat-
ment approaches have been proposed for the changes in 
anatomical structures due to various parameters but have 
not exclusively pointed to changes in air column.6,7 It is 
known that neither static CT nor 4DCT simulation scans 
will capture the potential variability of the air column that 
can be seen on a daily basis.6,7 Air volume variability in 
the stomach and bowel is commonly observed in clinical 
practice on imaging studies and such variability in the air 
column can be seen during the course of radiation treat-
ment for abdominal malignancies.
Furthermore, implementation of intensity modulated radi-
ation therapy (IMRT) has been used for treating GI malig-
nancies that has led to tighter margins around tumour 
volumes with optimal goals of dose escalation, increased 
conformality of target volumes and minimization of radia-
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this technique generally requires that the target volumes be well 
understood so that they are not inadvertently missed.8–10 For the 
reasons of dose escalation and improved conformality, IMRT 
approaches for treating pancreatic cancer have been proposed 
and explored11,12 except the motion management in photon 
beam. Such exploration involves non-coplanar beam arrange-
ments but the advantage is not clearly understood.13 Concerns 
arise from the complexities in accurately treating pancreatic 
cancer due to factors such as gastric air column and related organ 
motion.7,14 The anatomical position of the pancreas inside the 
abdominal cavity related to the aforementioned changes inevi-
tably leads to movement in the target volume position and loca-
tion of OARs with respect to isocentre location. Consequently, 
image guidance plays a key role in accurately treating pancre-
atic cancer with IMRT.15 Image guidance also provides leg work 
for adaptive therapy which has been advocated.6 Now with the 
acquisition of frequent cone beam CT (CBCT) during the course 
of radiation therapy, such variability can be monitored and 
image-based setup adjustments can be made.
Even though CBCT can provide the confidence in our isocentre 
position localization, the abdominal structural deformation due 
to gastric air volume and subsequent dosimetric consequences 
on pancreatic cancer target volumes is not fully understood. 
Our goal here is to compare the “planned dose” to “actual dose” 
delivered to target volumes in the treatment of pancreatic cancer 
that has poor prognosis. This study used IMRT with CBCT for 
image-guided radiation therapy to improve dose delivery thus 
probably outcome.
MethODs AND MAteRiAls
Pancreatic cancer in our centre was relatively rare, thus accruing 
a  large number of patients was not possible. Nine consecutive 
patients treated for pancreatic cancer with IMRT were chosen 
under the  Institutional Review Board exempt status for retro-
spective analysis. During the CT simulation process, each 
patient was properly immobilized in a vacloc and scanned using 
a 4DCT (Picker CT Scanner). As per departmental protocol, 
no explicit instructions were given to patients in regards to 
oral intake (foods or liquid) prior to the simulation or for their 
treatments. Target volumes and OARs were delineated. Patients 
were planned using Eclipse treatment planning system (Varian 
Medical Systems, Palo Alto, CA) with analytical anisotropic 
algorithm v. 11.1 for inhomogeneity correction. IMRT plans 
using typically a 7 to 9 non-coplanar beam arrangement were 
created. These plans were designed with target goals to achieve 
95% planning target volume (PTV) coverage with at least 95% 
of the prescribed dose while sparing OARs as much as possible, 
which is common practice.16  Even though such criterion is not 
recommended in ICRU-8317 for IMRT where D50 is advised. 
All patients had prescription doses of 50 or 50.4 Gy (mean dose 
50.1 Gy) to the PTV2, which covered areas of either gross disease 
or where there was clinical suspicion of microscopic spread. In 
nearly all cases, uninvolved regional lymphatics were covered by 
a second lower dose target volume, PTV1, with a prescribed dose 
of 45 Gy. These patients with lower two dose levels were treated 
with a simultaneous integrated boost technique using 25 total 
fractions treated 5 days per week.
Patients were treated daily after obtaining kilovoltage (kV) 
orthogonal imaging for isocentre localization matched on target. 
Each patient also underwent multiple CBCTs for isocentre and 
volume verification during the course of treatment. The institu-
tional practice was to match image set with CBCT and shift >5 
mm in any direction was applied before patient treatment. There 
was no 6 degree of freedom table at our institution. Anywhere 
from 3 to 6 CBCTs were obtained on each patient with a total of 
41 CBCTs acquired and an average number of CBCTs per patient 
of 4.6. For each CBCT, the images were exported to the treatment 
planning system for image fusion with the actual simulation CT. 
These acquired CBCTs were then used for repeated target delin-
eation. Air column was contoured slice by slice and volume was 
then estimated. The treatment planning was performed without 
optimization so comparison could be made with the initial simu-
lation CT scans.
Each CBCT image was fused to the simulation CT using bony 
anatomy as well as identified soft tissues. Once a CBCT was fused 
accurately, the target volumes were traced onto each CBCT by 
superimposing or blending the image sets. The “external” or 
“body” contour was recreated for each case as well as the “air 
volume”, consisting of gastric air and bowel gas. This volume was 
contoured individually onto each CBCT and recorded in cubic 
centimetres. From the fusion, the location of the original plan’s 
isocentre was also drawn on each CBCT to give a surrogate point 
for isocentre placement.
CBCT images have been used successfully for dose calcula-
tion with proper CT number to electron density conversion as 
described in literature.18–24 Different CT-electron density file 
of a CT phantom with various kV and filter on imaging system 
was acquired as described elsewhere.25 These files were appro-
priately used after importing the images for dose calculation in 
this study. The on-board imaging based CBCT v.n 2.1 (Varian 
Medical System) was used in this study. Dosimetric accuracy 
of CT-based planning has been completed during treatment 
planning system  (TPS) commissioning based on CT-electron 
density curve to within ± 2% for various clinical cases. The same 
is expected of CBCT data when a different CT-electron density 
file is used.
Next, the previously used IMRT plans from each case were copied 
and pasted onto the patients’ CBCT scans, effectively creating a 
radiation treatment plan with the same beam arrangement on 
each CBCT image set (Figure 1). A new set of CT number and 
electron density curve for the CBCT was used for dosimetry. 
The fields were aligned onto the CBCT’s at the isocentre that was 
placed from the planning CT registration. Monitor Units (MU) 
from individual treatment beams were obtained and recorded 
from the initial IMRT plans. To ensure the accuracy and validity 
of this process, the newly created IMRT plans were calculated 
using the same fluence and fixed MUs from the original treat-
ment plans as this was delivered to the patient on a daily basis. 
The CBCT dose calculation was not optimized, rather treat-
ment planning system derived fluence and MU were used for 
dose calculation. Finally, anterior to posterior (AP) separation 
was measured on all CT data sets at the isocentre so that CBCT 
3 of 6 birpublications.org/bjr Br J Radiol;91:20170512
BJRFull paper: Dosimetric impact of air column
Figure 1. Axial (top row) and sagittal (bottom row) images of a pancreatic cancer patient. The left most image is the simu-
lation CT followed by the weekly CBCT images. Note that the gastric content is variable weekly from simulation to treat-
ment. Red colour GTV and teal PTV contour. CBCT, cone beam CT; GTV, gross tumour volume; PTV, planning target volume. 
Figure 2. Variability of air volume on serial CBCTs compared 
to simulation CT for each patient. Colour bars represent 
weeks. CBCT, cone beam CT.
Figure 3. Correlation between the dose covering 100% of the 
PTV and air volume in cm3 taken from the 50 treatment plans 
(9 from the initial simulation CT’s and 41 CBCT’s). CBCT, cone 
beam CT; PTV, planning target volume.
dimensions could be compared to those of the planning CTs to 
see any gross changes in body structure or weight loss.
Results
The volume of the air column measured from the simulation 
CTs was variable among our patients with a range of 152 to 
852 cm3. The average air column on the nine planning CTs was 
400 ±  210 cm3 (one SD). The variability of the measured air 
volume from CBCTs was larger with a range of 144 to 1100 cm3. 
The average air column on the 41 CBCTs was 347 ±  282 cm3. 
When comparing each patient’s air volume from the initial simu-
lation CT to individual CBCTs, air volumes ranged as much as 
± 80% as shown in Figure 2 for all patients.
To understand how air column changes related to physical 
dimensions, we measured AP thickness on all CT scans, including 
the simulation and CBCTs. The average patient AP separation 
at isocentre was 22.4 cm (range 20.4–25.3 cm) on the simula-
tion scans. The average patient AP separation of the CBCTs at 
isocentre was also 22.4 cm (range 20.0–25.4 cm). This range of 
AP dimensions corresponded to a maximum difference of 2.8% 
when comparing each patient’s AP separation on initial planning 
CT to that patient’s averaged CBCT AP separation value.
Dose volume histogram (DVH) analysis was used to evaluate 
target volume coverage. We evaluated the high dose PTV2 from 
the initial treatment plans and compared this to the coverage this 
volume received on the individual CBCT plans. For the initial 
plans, 100% of the PTV was covered by 91.7% of the prescrip-
tion dose. When this was compared to the plans created on the 
CBCTs, it was found that 100% of the PTV was covered by 88.4% 
of the prescribed dose thus a reduction of 3.3%. Comparing 
the PTV coverage on DVH between the actual plans and the 
CBCT plans across the nine individual patients, the largest 
difference in relative dose coverage was −5.5% (SD = 4.8) and 
smallest difference between actual and CBCT plans was +0.1% 
(SD = 0.8). The average difference in relative dose from the CBCT 
plans compared to the actual plans was 3.3% reduction across 
our cohort of patients. To see if there was a correlation between 
the dose covering 100% of the PTV and air volume in cm3 of the 
50 plans (9 from the initial simulation CT and 41 CBCT plans), 
these two variables were plotted relative to each other. The resul-
tant trend line was nearly constant and linear as described by the 
equation y = 0.0019 × +88.0, R2 = 0.0149 shown in Figure 3. This 
dose reduction is probably due to air column. But this indicates 
that there is no correlation between dose covering 100% and air 
volume.
DisCussiON
Pancreatic cancer has relatively poor prognosis that may be 
due to clinical and technical difficulties. Radiation therapy for 
GI malignancies can be difficult due to internal changes to the 
patient’s anatomy caused by multiple factors including air in the 
GI tract. Variability of gastric and bowel gas is inherent and thus 
creates potential uncertainties in daily setup variances along 
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Figure 4. Isodose distribution in axial (top row) and sagittal (bottom row) view of the above pancreatic cancer patient. The left 
most image is CT-simulated image treatment plan. The rest are the weekly CBCT images on which dose calculation was performed 
based on the image fusion.
with the PTVs and OARs as shown in Figure 4. This variability 
of targets and OARs due to air column is of particular concern 
when attempts are made for dose escalator to spare normal 
tissues and reducing margin around target for decreased toxicity. 
In treating pancreatic cancer, IMRT has been suggested as an 
alternative to three-dimensional conformal radiation therapy 
(3DCRT) by optimization to achieve increased target dose and 
reduce normal tissue complications.11,12 Furthermore, in dose 
escalation studies with hypofractionated stereotactic body radi-
ation therapy (SBRT) for the treatment of pancreatic cancer, it 
has been shown that air volume differences between treatments 
can have a significant impact on the dose delivered to the target 
volumes.26 The central focus of this research was to evaluate the 
impact of air column on the dose coverage to target volumes for 
patients with pancreatic cancer treated with IMRT where the air 
column is variable in position and amount daily.
To evaluate potential dosimetric differences that could occur 
from changes in air column during IMRT for pancreatic cancer, 
we compared actual treatment plans from nine patients to the 
CBCT scans acquired on nearly a weekly basis during treatment. 
These CBCTs were initially intended to aid in image guidance for 
target localization. To make this comparison between a CT scan 
used for treatment planning and CBCT used for image guidance, 
dose calculation linearity between a conventional planning CT 
and a CBCT had to be established. CBCT-based dose calcula-
tions can be complicated by inaccuracies in the conversion of CT 
values to electron densities due to difference in scatter contri-
bution and CBCT acquisition parameters. Furthermore, the 
significant degree of variance when calculating dose between the 
two modalities (CT and CBCT) would distort the results of any 
such comparison. However, the magnitude of dose differences 
from CT number in soft tissues has been found to be relatively 
minimal25 and dose calculation based on individual electron 
density curves could be fairly accurate.
Several institutions have undertaken studies to investigate the 
use of CBCT for IMRT planning and the linear relationship of 
CBCT IMRT planning with conventional CT methods. One such 
study compared CBCT planning to conventional CT planning 
for IMRT in patients with head and neck cancer.27 Hounsfield 
Unit (HU) mapping from conventional CTs were applied to the 
CBCTs prior to dose calculation. This revealed the overall differ-
ences between the dose calculation based on the mapped CBCT 
scans and the conventional CT scans were generally within 1%. 
Another institution evaluated dose accuracy using site-specific 
calibration and investigated HU to electron density conversion 
stability.24 Different anatomical sites were analysed including 
the abdomen and pelvis. HUs for various tissues were compared 
between CBCT and conventional CT as well as minimum, 
maximum and mean doses to target volumes. The authors 
concluded that there was a 2% difference between the two plan-
ning methods. HU mapping methodologies have been carried 
out on homogeneous and inhomogeneous phantoms with dosi-
metric consequence due to HU variations for CBCTs as well.28 
Results indicate variance from conventional CT scans of less 
than 1% and close agreement in isodose lines. A fourth group 
has done similar dosimetric comparisons and concluded that 
less than 1% difference was found in calculated dose to targets 
for a complex inhomogeneous phantom between CBCT images 
and planning CT images.29 Just as in our study, all the facilities 
conducting the aforementioned research utilized Varian linear 
accelerators with CBCT image acquisition and Eclipse treat-
ment planning system with analytical anisotropic algorithm for 
dose inhomogeneity corrections. Therefore, there is seemingly a 
consensus that CBCT images can be used to calculate dosimetric 
parameters accurately in radiotherapy planning, which is also in 
agreement with the data provided by Das et al25.
Using CBCT for treatment planning in our study, we found 
there is a potentially substantial variation in air volume on any 
given scan. Patients in our series had changes in air volume as 
great as ± 80% on CBCT when compared to initial simulation 
CTs used for treatment planning. The AP dimension could be 
a quick indication of gastric volume. However, these changes in 
air column had a seemingly minimal effect on the measured AP 
dimension with both the average measurement on simulation 
CT and CBCT for all scans being the same at 22.4 cm. Further-
more, our results show that these differences in air volume over 
the course of treatment have a minimal impact on target volume 
coverage. The largest average difference in 100% of a PTV being 
covered was a 5.5% reduction in dose compared to the coverage 
delivered in the actual treatment plan. Across our total cohort of 
patients, the average difference in relative planned vs delivered 
dose was only −3.3%. Furthermore, no instructions were given 
to our patients for food or liquid oral intake prior to simulation 
or daily treatments. Given this, our results are consistent with 
others’ findings when treating upper GI malignancies without 
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